Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has a planned timetable for Arikayce liposomal becoming available to patients on the NHS.

A policy proposal for Arikayce Liposomal, also known as Amikacin, is being considered by NHS England and is progressing through its methods process. The policy proposal is currently undergoing stakeholder testing and a date for consideration at the Priorities Advisory Group has not yet been determined.